This book examines the evolving dynamics driving philanthropy asWestern society struggles to meet today's many challenges. Theauthor takes a hard look at the sensitive issues of democraticlegitimacy, accountability and credibility in the context of civilsociety, as well as the changing policy environment in whichfoundations operate.
He argues that effective philanthropy is "impact driven" anddepends on a strategic mix of methodologies that reach beyondgrant-giving. The arguments challenge the status quo and deliver awake up call to philanthropists on both sides of the Atlantic.
The book intends to spark an ongoing debate as the sectorstrives to strengthen its relevance and make a real difference in aworld that is becoming more complex than ever before.
* About 80% to 90% of existing literature is from the Anglo-Saxonperspective and written by academics. This book represents auniquely European perspective from a practitioner with more than 20years experience in the field.
* Because of foundations' hefty - and growing - financialendowment, the questions of value creation, democratic legitimacy,intergenerational transfer of wealth, the payout rate andaccountability are being debated. The author offers a Europeanperspective on these issues.
* A new and dynamic philanthropy is emerging as foundations takeon new roles in communities. These roles are examined within thecontext of different civil society models. A new role is emerging -that of convenor, or "catalytic converter", which brings variousstakeholders together around a particular issue and then advocatesfor political and/or social change. The author ultimately arguesfor "impact driven" philanthropy and gives practical examples ofhow to get there.
* Challenges in our globalized world require both local andglobal solutions. The author urges European foundations to becomemore European and address the myriad challenges facing areintegrated continent. He also urges them to assume a strongerleadership role on global issues such as HIV/AIDs, poverty, ethicalchallenges and drug policy.